What’s New

    1. The law firms of Flaherty McCarthy LLP and Waddell Phillips P.C.  have commenced a multi-million dollar proposed Class Proceeding against LIVANOVA PLC, SORIN GROUP DEUTSCHLAND GMBH and SORIN GROUP USA, INC. seeking damages arising from the negligent design, testing, marketing and sale of the defendants’ Sorin 3T System. This is a medical device regulated in Canada pursuant to the Medical Devices Regulation, SOR/98-282, which is a Regulation to the Food and Drugs Act, RSC 1985, c F 27.The Sorin 3T System is used during cardiac surgery to regulate blood temperature by circulating water through tubes into a heat exchanger where blood is pumped into separate chambers during surgery. As the water passes through the water tanks and other areas it is aerosolized into a vapor. The Plaintiff alleges that this vapor containing NTM which exits from the device and is pushed into the ambient air of the operating room through the System’s exhaust fan. When placed in an operating room, the contaminated vapor from the System directly enters the sterile surgical field and the patient’s open body through their open surgical site.The primary bacteria at issue, inter alia, M. Chimaera and M. Abscessus, are subspecies of Nontuberculous Mycobacterium (“NTM”) that occurs naturally in the environment and rarely causes illness. NTM poses a unique risk to patients whose organs and chest cavities are directly exposed to the bacteria during surgery. Because NTM is a slow growing bacterium, it generally takes anywhere from two weeks to five years before manifestation of an NTM infection, which most commonly results in pulmonary or cardiovascular disease. Symptoms of NTM infection are frequently non specific and may include any of the following: fever, pain, heat or pus around a surgical incision, wound healing issues, night sweats, joint and muscle pain, weight loss, and fatigue. The diagnosis of an NTM infection requires targeted culturing and/or molecular diagnostic testing. While an NTM infection diagnosed early on may be successfully treated with a series of antibiotics, there is a significant risk of death in cases with delayed diagnoses and/or in individuals with considerably weakened immune systems.The proposed Class Proceeding seeks damages on behalf of (a) All persons in Ontario and elsewhere in Canada, except Quebec, who underwent surgery during which the Sorin 3T Heater Cooler System (the “Sorin 3T System”) was used (the Patient Class) and were exposed to invasive cardiovascular infections identified as NTM, specifically M. Chimaera and M. Abscessus, which are subspecies of Nontuberculous Mycobacterium (“NTM”); and (b) all dependents of Members of the Patient Class as defined by Section 61 of the Family Law Act R.S.O. 1990 s.F.3 s.61 and similar legislation in other provinces (the FLA Class);The allegations contained in the Statement of Claim have not yet been proven in Court.
    2.  A copy of the Statement of Claim can be found here.
    3. At this point, the matter is a proposed class proceeding. As a class member, you do not have to do anything more to be involved in this lawsuit. You will be a member of the class until you are given the opportunity to opt out, which will be your choice.
    4. The Amended Amended Statement of Claim has been issued and served on the Defendants.
    5. The Defendants have not yet delivered a statement of defence.
    6. A motion for certification of the action as a class action is currently scheduled for May 23-24, 2019 .
    7. An application for funding for this action was heard by the Class Proceedings Fund on April 18, 2018. The funding application was successful. The Class Proceedings Fund will provide some funding for the costs of disbursements incurred in prosecuting the case, and will provide an indemnity to the plaintiffs for any adverse cost awards made by the court. In exchange, the Fund will be entitled to receive 10% of the net proceeds of any judgment or settlement achieved for the class.